an infant formula phoenix, page-14

Crumbs there seems to have been a big step up and push for a2 conversion since the agm, I do wonder if total overall production will exceed at HY reporting, plus perhaps there may be some early traction coming through from Akarola now that it’s selling on JD.com, and at half the retail price of a2 platinum.

http://search.jd.com/Search?keyword=akarola&enc=utf-8&wq=akarola&pvid=gtwnrqii.wcj917

That can only add to production volumes going forward given the Chinese very probably are buying the ‘New Zealand clean green’ message over the ‘a2 protein’ message at this stage, in my opinion.

SML win both ways, a higher production margin from A2M, and 25% of net profits, when they happen, from Akarola sales.

Plus I reckon some analysts within their estimates may not be recognising the higher gross and net margins that should result from the spike in infant formula production we have been seeing. They still seem to be projecting around 3.5% net margins, even after SML have told us that gross margins will be higher, hmmm.

Well done SML on the ‘synlait sure’ website, looks good, http://synlaitsure.co.nz/

Nice to see a golden cross on the charts too for those who actually do anything about them.